Logo
A

Alladapt Immunotherapeutics, Inc.

36 employees

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2018

Funding rounds raised

Total raised

$119M

from 8 investors over 8 rounds

A

Alladapt Immunotherapeutics, Inc. raised $50M on August 30, 2022

Investors: Hercules Capital, Inc.

A

Alladapt Immunotherapeutics, Inc. raised $119M on June 22, 2022

Investors: Red Tree Venture Capital, Patient Square Capital, Gurnet Point Capital and WestRiver Group

A

Alladapt Immunotherapeutics, Inc. raised $60M on February 20, 2020

Investors: TRB Advisors LP, Camino Partners (formerly Equilibra) and Gurnet Point Capital

FAQ